Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

Joseph M. Parker, Chad K. Oh, Craig LaForce, S. David Miller, David S. Pearlman, Chenxiong Le, Gabriel J. Robbie, Wendy I. White, Barbara White, Nestor A. Molfino

Research output: Contribution to journal › Article › peer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma'. Together they form a unique fingerprint.

Medicine & Life Sciences